Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Current Assets: 2019-2024

Historic Current Assets for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $878.1 million.

  • Beam Therapeutics' Current Assets rose 16.18% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 16.18%. This contributed to the annual value of $878.1 million for FY2024, which is 27.49% down from last year.
  • Latest data reveals that Beam Therapeutics reported Current Assets of $878.1 million as of FY2024, which was down 27.49% from $1.2 billion recorded in FY2023.
  • Over the past 5 years, Beam Therapeutics' Current Assets peaked at $1.3 billion during FY2021, and registered a low of $308.3 million during FY2020.
  • For the 3-year period, Beam Therapeutics' Current Assets averaged around $1.1 billion, with its median value being $1.1 billion (2022).
  • Its Current Assets has fluctuated over the past 5 years, first soared by 312.88% in 2021, then fell by 27.49% in 2024.
  • Beam Therapeutics' Current Assets (Yearly) stood at $308.3 million in 2020, then surged by 312.88% to $1.3 billion in 2021, then fell by 14.15% to $1.1 billion in 2022, then grew by 10.81% to $1.2 billion in 2023, then dropped by 27.49% to $878.1 million in 2024.